In vitro and in vivo evaluation of a novel 68Ga-labeled BVD15 analogue for neuropeptide Y1 receptor imaging with positron emission tomography

新型 68Ga 标记的 BVD15 类似物用于正电子发射断层扫描神经肽 Y1 受体成像的体外和体内评估

• 批准号: 331941
• 负责人: Zhang Chengcheng
• 金额: $ 0.07万
• 依托单位: BC Cancer, part of PHSA (Vancouver)
• 依托单位国家: 加拿大
• 财政年份: 2015
• 资助国家: 加拿大
• 起止时间: 2015-05-01 至 2016-05-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=331941&lang=en
• 关键词: Breast Cancer; Diagnostic Imaging; Imaging Probe Evalution; Imaging Probe Synthesis; Molecular Biology; Molecular Imaging; Positron Emission Tomography

Breast cancer is the second most common cancer worldwide with 1.68 million new cases and 522,000 deaths in 2012. Medical imaging-based diagnosis could help identify breast cancers at early stages, and substantially reduce mortality rate by providing early

乳腺癌是全球第二大常见癌症，2012 年有 168 万新发病例和 522,000 例死亡。基于医学影像的诊断可以帮助早期发现乳腺癌，并通过提供早期诊断来大幅降低死亡率。